Lv21
140 积分 2021-03-04 加入
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
16天前
已完结
CDK12-Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade
19天前
已完结
A review of strategies to overcome immune resistance in the treatment of advanced prostate cancer
19天前
已关闭
基于血液肿瘤突变负荷检测的现状与挑战
25天前
已完结
[Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer]
25天前
已完结
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
1个月前
已完结
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2个月前
已完结
Characteristics of Lung Cancers Harboring NRAS Mutations
3个月前
已完结
Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study
3个月前
已完结
Added Diagnostic Utility of Clinical Metagenomics for the Diagnosis of Pneumonia in Immunocompromised Adults
4个月前
已完结
皖公网安备34019202002308
